Clinical Trial Update: Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing aromatase inhibitors plus chemotherapy versus chemotherapy alone as neoadjuvant treatment for postmenopausal HR-positive brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• aromatase inhibitors plus chemotherapy

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Neoadjuvant Therapy | Phase 3 | Status: UNKNOWN